● Respiratory Tract Infections (RTIs)

Respiratory tract infections are infections of parts of the body involved in breathing, such as the sinuses, throat, airways or lungs. Due to the differences of infections organism, RTIs divided into upper and lower respiratory tract, symptoms include cold, bronchiolitis, pneumonia, croup, otitis media. Viruses are the most common cause of RTIs, such as influenza viruses, respiratory syncytial virus, chlamydia pneumoniae, human parainfluenza virus, and coronavirus.

Lower respiratory tract infections (LRTI) remained the world’s most deadly communicable disease. WHO (2019) reported that LRTI ranked as the 4th leading cause of death globally and 4th leading cause of disability-adjusted life years. Besides, Acute Respiratory Tract Infection (ARTI) is one of the most common infectious diseases and its incidence ranked as 1st among acute infectious diseases.

ZBI’s respiratory nucleic acid detection assay helps to faster the detection speed, to improve the sensitivity and specificity, to shorter the window period, and to decrease the cost. 

● Intended Use

The kit is intended to qualitatively detect ORF1ab and E genes from 2019-nCoV in oropharyngeal swabs and sputum specimens from suspected pneumonia cases and other cases who need to diagnose whether is infected by 2019-nCoV.The kit should be performed by qualified and trained staff.

***For professional use

● Features

FUNCTION: Isothermal amplification to detect RNA nucleic acid pathogens

ACCELERATION: Up to 30min to complete test

STRENGTH: High sensitivity & specificity

TECHNOLOGY: Patent technology with low requirement of instruments

EVALUATION: Using 18SrRNA to control the sample quality

RECENT: Positive result reflects present infection